Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

I. Hashimoto, J. Kodama, N. Seki, A. Hongo, M. Yoshinouchi, H. Okuda, T. Kudo

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib-IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalBritish Journal of Cancer
Volume85
Issue number1
DOIs
Publication statusPublished - Jul 6 2001

Fingerprint

Vascular Endothelial Growth Factor C
Uterine Cervical Neoplasms
Lymph Nodes
Messenger RNA
Neoplasm Metastasis
Lymphangiogenesis
Lymph
Lymph Node Excision
Hysterectomy
Reverse Transcription
Blood Vessels
Neoplasms
Multivariate Analysis

Keywords

  • Cervical cancer
  • Lymph node metastasis
  • VEGF-C

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. / Hashimoto, I.; Kodama, J.; Seki, N.; Hongo, A.; Yoshinouchi, M.; Okuda, H.; Kudo, T.

In: British Journal of Cancer, Vol. 85, No. 1, 06.07.2001, p. 93-97.

Research output: Contribution to journalArticle

Hashimoto, I. ; Kodama, J. ; Seki, N. ; Hongo, A. ; Yoshinouchi, M. ; Okuda, H. ; Kudo, T. / Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. In: British Journal of Cancer. 2001 ; Vol. 85, No. 1. pp. 93-97.
@article{2946d5b7e32943f599cbbbae036dbb3c,
title = "Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer",
abstract = "Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib-IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis.",
keywords = "Cervical cancer, Lymph node metastasis, VEGF-C",
author = "I. Hashimoto and J. Kodama and N. Seki and A. Hongo and M. Yoshinouchi and H. Okuda and T. Kudo",
year = "2001",
month = "7",
day = "6",
doi = "10.1054/bjoc.2001.1846",
language = "English",
volume = "85",
pages = "93--97",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

AU - Hashimoto, I.

AU - Kodama, J.

AU - Seki, N.

AU - Hongo, A.

AU - Yoshinouchi, M.

AU - Okuda, H.

AU - Kudo, T.

PY - 2001/7/6

Y1 - 2001/7/6

N2 - Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib-IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis.

AB - Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib-IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis.

KW - Cervical cancer

KW - Lymph node metastasis

KW - VEGF-C

UR - http://www.scopus.com/inward/record.url?scp=0035816231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035816231&partnerID=8YFLogxK

U2 - 10.1054/bjoc.2001.1846

DO - 10.1054/bjoc.2001.1846

M3 - Article

VL - 85

SP - 93

EP - 97

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -